what are glp 1 receptor agonists GLP1 Agonists—Effects beyond Obesity and Diabetes GLP-1 Receptor Agonists - Slender

Hao Xu, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

( 10.1038/s41591-021-01584-3) [DOI] [PubMed] [Google Scholar] Salvatore T, Galiero R, Caturano A, Vetrano E, Rinaldi L, Coviello F, Di Martino A, Albanese G, Colantuoni S, Medicamento G, et al

[DOI] [PubMed] [Google Scholar] 129.A Study of Tirzepatide (LY3298176) Versus Placebo in Participants with Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin

They are different treatments with different risk profiles

Understanding the economic implications and addressing the accessibility issues of combination therapy is crucial, especially as healthcare systems aim to optimize resource allocation while enhancing patient care